The authors developed a peptidized EV platform to enhance the delivery of anti-apoptotic Bcl-2 antisense oligonucleotide G3139 (antisense phosphorothioate oligodeoxynucleotide to Bcl2) into tumor cells. The gene discussed is BCL2; the disease is neoplasm.